$INJ (Injective) has entered a decisive markdown phase as of December 24, 2025, currently trading near $4.46 – $4.65. The asset is struggling under intense bearish pressure, down approximately 7.7% over the past week and nearly 91.5% from its March 2024 all-time high of $52.62. Despite fundamental progress, including a refined staked INJ ETF filing by Canary Capital and a v1.17.2 mainnet upgrade on December 18, technical momentum remains firmly negative as traders favor a "sell the rip" approach.
Technical indicators reinforce this bearish outlook, with
$INJ pinned well below its 50-day SMA ($5.47) and 200-day SMA ($10.19). On the daily and 4-hour charts, technical summaries indicate a "Strong Sell" or "Bearish" rating. While a bullish MACD divergence is forming and the RSI (~37) is approaching oversold territory, the persistent lack of buy-side volume—which decreased 8.3% in the last 24 hours—suggests any relief bounces may be short-lived.
Support and Resistance Levels
Immediate Resistance: A formidable supply zone is located between $4.72 and $4.84, aligning with the 7-day SMA and the immediate pivot point. A reclaim of $5.23 (20-day SMA) is required to signal a structural shift.
Secondary Resistance: Stronger overhead resistance sits at $5.50 (the 23.6% Fibonacci level) and $7.00.
Immediate Support: The price is currently testing a thin floor at $4.43 – $4.51, which represents the current 52-week low.
Critical Support: A failure to hold $4.43 could trigger a rapid capitulation toward the $4.00 psychological level or deeper toward historical demand zones near $2.50.
The overall trend is characterized by institutional caution and "Extreme Fear" across the broader market, favoring continued downside for
$INJ .
Short Trade Signal
Margin: Isolated 2% to 5%
Leverage: 20x – 50x
Entry 1: 4.68
Entry 2: 4.84
Take Profits:
TP1: 4.43
TP2: 4.05
Or Take Profit from 100% to 500% ROI
Stop Loss: 5.05
Short
#INJ Here